European stocks advanced, rebounding from two days of losses, after Janet Yellen, nominated to be the next chairman of the Federal Reserve, said the U.S. economy must improve before monetary stimulus is pared. U.S. index futures and Asian shares also climbed.
Burberry Group Plc added 1.8 percent after saying first-half sales exceeded 1 billion pounds ($1.6 billion) for the first time as online revenue advanced. K+S AG rose 3.4 percent after reporting third-quarter earnings that beat estimates. RWE AG slid 5.7 percent after forecasting profit next year will almost halve because of weak power prices.
The Stoxx Europe 600 Index gained 0.8 percent to 322.48 at 8:05 a.m. in London. The gauge rallied for the past five weeks as the Federal Reserve maintained bond purchases and the European Central Bank lowered its key interest rate. Standard & Poor�� 500 Index futures rose 0.3 percent, while the MSCI Asia Pacific Index gained 0.9 percent.
Yellen said the economy and labor market are performing ��ar short of their potential��and must improve before the central bank can begin reducing monetary stimulus.
Top 5 Heal Care Stocks To Buy Right Now: GigaMedia Limited (GIGM)
Gigamedia Limited, through its subsidiaries, primarily engages in the operation of online games for online game players in Asia. The company provides a portfolio of online games, including MahJong, a traditional Chinese tile game; MMORPG, an Internet-based computer game; advanced casual games; and card, chance-based, and simple casual games. It also develops and licenses online poker, casino, and sports betting gaming software solutions, as well as offers application services for the online poker and casino markets primarily in the continental European markets. The company has strategic alliances with SoftStar Entertainment Inc., Neostorm Holdings Limited, XLGames Inc., Access China Holding Limited, Gorilla Banana Entertainment Corp., JC Entertainment Corporation, Possibility Space Incorporated, East Gate Media Contents & Technology Fund, and BetClic. GigaMedia Limited was founded in 1997 and is headquartered in Taipei, Taiwan.Advisors' Opinion:
- [By Eric Volkman]
GigaMedia (NASDAQ: GIGM ) results for the company's fiscal Q4 and 2012 have been released. For the quarter, revenue was $4.8 million, down by 34% from the $7.4 million in the same period the previous year. Attributable net loss, however, narrowed considerably to $15.4 million ($0.30 per diluted share) from Q4 2011's shortfall of $51.3 million ($1.01).
Hot Performing Stocks To Buy Right Now: Symantec Corporation(SYMC)
Symantec Corporation provides security, storage, and systems management solutions internationally. The company?s Consumer segment delivers Internet security, PC tune-up, and online backup solutions and services to individual users and home offices. Its Security and Compliance segment provides solutions for endpoint security and management, compliance, messaging management, data loss prevention, encryption, and authentication services to large, medium, and small-sized businesses, as well as offers solutions through its software-as-a-service (SaaS) security offerings. This segment?s products enable customers to secure, provision, and remotely manage their laptops, PCs, mobile devices, and servers. The company?s Storage and Server Management segment provides storage and server management, backup, archiving, and data protection solutions across heterogeneous storage and server platforms, as well as solutions delivered through its SaaS offerings to large, medium, and small-s ized businesses. Symantec?s Services segment offers implementation services and solutions, including consulting, business critical services, education, and managed security services. The company also provides various enterprise support offerings, such as annual maintenance support contracts, including content, upgrades, and technical support. It sells its products through its eCommerce platform, as well as through distributors, direct marketers, Internet-based resellers, system builders, ISPs, and retail locations worldwide. Symantec markets and sells its products through distributors, retailers, direct marketers, Internet-based resellers, original equipment manufacturers, system builders, and Internet service providers; and its e-commerce channels, as well as direct sales force, value-added and large account resellers, and system integrators. The company was founded in 1982 and is headquartered in Mountain View, California.Advisors' Opinion:
- [By Vanina Egea] and earnings growth (which came in better than expected on the last reported quarter), profit margins and other profitability ratios.
Additionally, I will evaluate which institutional investors bought the stock in the recent quarters (institutional backup can tell a lot about a stock), and the initiatives that the company is putting in motion in order to ameliorate its sales and margins.
The first step is analyzing Symantec Corp�� earnings growth. I am looking for companies that are able to expand both their quarterly and annual earnings by more than 15% a year. Last quarter the company generated 13% quarterly EPS growth when compared to the same quarter last year. Thus, I am not encouraged by SYMC�� numbers. Past growth winners (Apple, Baidu, etc.) generated consistent quarterly EPS growth above 15% and I am certainly looking for that level before investing.
In addition, SYMC generated three-year average annual EPS growth of 10%. This is an important metric to follow in growth stocks because it highlights how well the stock grew in the past years. I like to invest in companies that are growing consistently.
Let's take a look at SYMC麓s revenue growth. This is a key metric that needs to be analyzed before investing in a company, as it is one of the scarce figures that cannot be modified through accounting tricks and similar dodges.
The company reported a 5% quarterly revenue drop year over year. On the contrary, I look for companies that generate more than 15% in quarterly growth.
When betting on a company, an investor wants to see sales grow or improve over time ���nd not just in the last reported quarter. Looking at the company�� financials in comparison to previous years will give participants a much better idea of how well a company is doing. Symantec Corp generated a three-year average annual sales growth rate of 4%.
A New Strategic Plan
Accepting the problems in its
Hot Performing Stocks To Buy Right Now: Synergy Pharmaceuticals Inc (SGYP)
Synergy Pharmaceuticals, Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company�� lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC). The Company�� active pharmaceutical ingredients (APIs) and the final formulated drug products are manufactured for it by third party contractors.
As of December 31, 2011, the Company was developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor. As of December 31, 2011, the Company was dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat. It is also developing a second generation GC-C receptor analog, SP-333, which is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone.
The Company competes with Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.Advisors' Opinion:
- [By Monica Gerson]
Breaking newsTime Warner Cable (NYSE: TWC) reported a drop in its third-quarter profit. Time Warner Cable's quarterly profit fell to $532 million, or $1.84 per share, from $808 million, or $2.60 per share, in the year-ago period. To read the full news, click here. Synergy Pharmaceuticals (NASDAQ: SGYP) today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist and once-daily oral treatment, in adult patients with opioid-induced constipation (OIC). To read the full news, click here. Cigna (NYSE: CI) reported a 19% rise in its third-quarter earnings and lifted its full-year earnings outlook. To read the full news, click here. Charm Communications (NASDAQ: CHRM) announced today that the special committee of the Company's board of directors, consisting of independent directors Mr. Zhan Wang, Mr. Andrew J. Rickards and Mr. Gang Chen, has retained China Renaissance Securities (Hong Kong) Limited as its financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP as its legal advisor. To read the full news, click here.
Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
- [By Sean Williams]
Finally, Synergy Pharmaceuticals (NASDAQ: SGYP ) may have had the wildest week of them all. Synergy's share price spiked 16% on Tuesday as an analyst at Cantor Fitzgerald raised her peak sales estimate for plecanatide, the company's midstage drug for chronic idiopathic constipation and irritable bowel syndrome with constipation, to $1.58 billion from $1.05 billion, as clinical data has been stronger than expected. However, the company didn't return the favor to shareholders by -- the very next day, mind you ��announcing a secondary offering of 16.375 million shares. The downside of clinical-stage companies is the always apparent risk of dilution. Shares have lost 25% since their Tuesday close.
Hot Performing Stocks To Buy Right Now: Alleghany Corporation(Y)
Alleghany Corporation, through its subsidiaries, engages in the property and casualty, and surety insurance business in the United States. It underwrites specialty insurance coverages in the property, umbrella/excess, general liability, directors and officers liability, professional liability lines of business, and homeowners insurance. The company also writes surety products, such as commercial surety bonds and contract surety bonds. In addition, Alleghany Corporation owns and manages improved and unimproved commercial land, and residential lots in the Sacramento, California. As of December 31, 2010, the company owned approximately 320 acres of property in various land use categories. Further, it engages in the oil and gas exploration and production business. The company was founded in 1929 and is based in New York, New York.Advisors' Opinion:
- [By Matthew Argersinger]
Matching a stable of strong insurance businesses with intelligent investing is one of the key formulas Warren Buffett used to turn Berkshire Hathaway (NYSE: BRK-A ) (NYSE: BRK-B ) into one of the greatest investments of the past half-century. Fortunately for investors who weren't able to ride Buffett's market-crushing train, there are several smaller companies that have embraced Berkshire's formula with great success. One of those is Alleghany (NYSE: Y ) , a multi-line insurance company whose objective�is "to create value through owning and managing operating subsidiaries and investments, anchored by a core position in property and casualty reinsurance and insurance." Sound familiar?
- [By Damian Illia]
The firm is currently Zacks Rank # 2 - Buy, and it also has a longer-term recommendation of ��utPerform�� For investors looking for a Zacks Rank # 1 ��Strong Buy, Alleghany Corp. (Y), Berkshire Hathaway Inc (BRK.B) and Fidelity (FNF) could be the options.
- [By Chris Hill]
Which investors are worth following? In this installment of MarketFoolery, our analysts talk about why they're following Cook and Bynum's Richard Cook and Dowe Bynum, Martin Capital's Frank Martin, Alleghany's (NYSE: Y ) CEO Weston Hicks, and T. Rowe Price's (NASDAQ: TROW ) �Preston Athey.�